Clinical Trial Update: Georgia Memory Net Anti-Amyloid Monoclonal Antibody Registry

View source ↗

Summary

This clinical trial update describes the Georgia Memory Net registry for anti-amyloid monoclonal antibodies in Alzheimer's disease, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Georgia Memory Net anti-amyloid monoclonal antibody registry

Snippet

Sponsor: Emory University | Conditions: Alzheimer Disease | Status: RECRUITING